| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.64B | 22.67B | 23.77B | 22.62B | 20.79B | 22.37B |
| Gross Profit | 7.20B | 7.32B | 8.01B | 7.69B | 7.77B | 9.46B |
| EBITDA | 3.54B | 4.43B | 5.14B | 4.12B | 4.55B | 6.02B |
| Net Income | 2.26B | 2.30B | 2.80B | 1.93B | 3.27B | 4.59B |
Balance Sheet | ||||||
| Total Assets | 42.17B | 39.80B | 40.22B | 42.34B | 42.29B | 44.44B |
| Cash, Cash Equivalents and Short-Term Investments | 16.44B | 14.32B | 18.22B | 18.70B | 18.26B | 20.60B |
| Total Debt | 16.63B | 13.11B | 14.27B | 17.07B | 18.26B | 20.86B |
| Total Liabilities | 20.54B | 18.66B | 19.59B | 22.56B | 23.01B | 24.78B |
| Stockholders Equity | 21.41B | 20.92B | 20.40B | 19.52B | 19.04B | 19.41B |
Cash Flow | ||||||
| Free Cash Flow | 1.90B | 1.52B | 2.35B | 2.57B | 3.82B | 4.28B |
| Operating Cash Flow | 3.14B | 3.07B | 3.88B | 3.81B | 4.60B | 5.04B |
| Investing Cash Flow | 1.95B | -110.26M | 3.58B | -6.07B | 2.68B | 1.56B |
| Financing Cash Flow | -6.14B | -3.59B | -5.55B | -4.14B | -6.49B | -3.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$32.43B | 11.55 | 11.65% | 5.36% | -3.48% | -24.11% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | HK$20.15B | 24.23 | 42.05% | 2.53% | 20.78% | 18.37% | |
56 Neutral | HK$82.22M | 27.02 | 2.58% | ― | 5.99% | -74.29% | |
48 Neutral | HK$981.03M | 92.72 | -12.38% | ― | 39.29% | -71.82% | |
44 Neutral | HK$17.41B | -43.19 | -4.30% | 5.00% | 2.79% | -170.67% |